Skip to content
Rockwell Automation and Cytiva Introduce Figurate SCADA

Rockwell Automation and Cytiva Introduce Figurate SCADA

Arcweb May 4, 2026

Rockwell Automation and Cytiva, a Danaher company, have jointly launched the Figurate Supervisory Control and Data Acquisition (SCADA) system designed to help address digital bottlenecks in biopharmaceutical manufacturing. The platform is designed to help support connectivity across multiple instrument vendors and modalities, further enabling broader digital integration in modern bioprocessing environments.

Many biopharma facilities operate with proprietary systems that are unable to communicate effectively with one another. This fragmentation can create operational silos, more reliance on manual workarounds, and potential data integrity risks. The Figurate SCADA platform is positioned to help address these challenges through an open architecture that allows integration with third-party equipment and provides real-time visibility into unit operations through a single interface.

The platform integrates with Cytiva bioprocessing equipment and Rockwell Automation’s FactoryTalk software suite, helping to enable interoperability across systems. It is designed to scale from process development to commercial manufacturing without requiring system redesign, helping to support continuity as operations expand.

Built-In Interoperability: Integration with Cytiva equipment and FactoryTalk software helps to enable connectivity across systems.

Scalable Growth: The platform supports expansion from development to commercial manufacturing without redesign.

Cost-Effective Compliance: A more streamlined digital system supports cGMP requirements while helping to manage capital and operational costs.

Rapid Implementation: Pre-engineered templates and modular design help to reduce deployment and validation timelines.

Enhanced Operational Insight: Centralized alarms, real-time monitoring, and batch reporting are tailored to bioprocess workflows.

Demand for -generation process control systems continues to grow as biopharma organizations move toward more data-driven operations, including process intensification and continuous manufacturing. Equipment fragmentation remains a persistent challenge, particularly for organizations transitioning from research and development to clinical and commercial scales.

The platform is now available globally.

Follow ARC Advisory Group for the latest trends in sustainability, automation, and generation technology.

Extracted Entities

Platforms (1)